Unlocking the Potential of ACBD7 as a Drug Target and Biomarker

Target Name: ACBD7

NCBI ID: G414149

ACBD7

Unlocking the Potential of ACBD7 as a Drug Target and Biomarker

Introduction

The acyl-CoA binding domain (ACBD) is a conserved protein region that can be found in various cellular signaling pathways. One of the most well-known functions of ACBD is its role in the regulation of lipid metabolism, including the transport of fatty acids into mitochondria for energy production. The protein ACBD7, which contains 7 amino acids, has been identified as a potential drug target and biomarker for various diseases, including cardiovascular disease, diabetes, and neurodegenerative disorders.

ACBD7: Structure and Function

The ACBD7 protein is a member of the superfamily of evolutionarily conserved transmembrane proteins, known as the ACBD subfamily. This subfamily is characterized by the presence of an ACBD domain, which is responsible for the protein's unique structure and function. The ACBD domain is a 120 -amino acid-long region that is responsible for the protein's stability, solubility, and interaction with other molecules.

The ACBD7 protein is expressed in various tissues and organs, including heart, brain, and peripheral tissues. It is also highly transmembrane, which means it spans the membrane of the cell and can interact with both intracellular and extracellular molecules. functions as a scaffold, playing a crucial role in the regulation of various cellular processes, including cell signaling, protein transport, and lipid metabolism.

Drug Target Potential

The ACBD7 protein has been identified as a potential drug target due to its unique structure and function. Several studies have shown that ACBD7 can interact with various drug molecules, including small molecules, peptides, and proteins. Additionally, the ACBD7 protein has been shown to play a role in the regulation of cellular signaling pathways, including the production of reactive oxygen species (ROS) and the modulation of inflammation.

One of the most promising aspects of ACBD7 as a drug target is its potential to modulate the activity of various enzymes involved in lipid metabolism. The ACBD7 protein has been shown to interact with various lipid enzymes, including fatty acid amide hydrolase (FAAH), which is involved in the metabolism of fatty acids. By modulating the activity of these enzymes, ACBD7 has the potential to treat various diseases associated with lipid metabolism, including cardiovascular disease and diabetes.

Biomarker Potential

The ACBD7 protein has also been identified as a potential biomarker for various diseases. Its unique structure and function make it a promising candidate for the development of diagnostic tools and therapeutic targets. For example, ACBD7 has been shown to be involved in the regulation of cellular signaling pathways, including the production of reactive oxygen species (ROS) and the modulation of inflammation. By detecting changes in the expression and activity of ACBD7, researchers may be able to diagnose and monitor various diseases, including neurodegenerative disorders and cardiovascular disease.

Methods

To further explore the potential of ACBD7 as a drug target and biomarker, researchers have used various techniques to study its function. These techniques include biochemical assays, cell-based assays, and mass spectrometry.

Biochemical assays, such as Western blotting and immunoprecipitation, have been used to detect the presence and activity of ACBD7 in various cellular signaling pathways. These assays have shown that ACBD7 is involved in the regulation of fatty acid metabolism, including the transport of fatty acids into mitochondria for energy production.

Cell-based assays, such as live cell imaging and assays for protein-protein interactions, have been used to further study ACBD7's role in the regulation of cellular signaling pathways. These assays have shown that ACBD7 plays a role in the production of reactive oxygen species (ROS) and the regulation of inflammation.

Mass spectrometry, which is a powerful tool for the identification and quantitation of proteins, has also been used to study AC

Protein Name: Acyl-CoA Binding Domain Containing 7

Functions: Binds medium- and long-chain acyl-CoA esters

The "ACBD7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ACBD7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets